Trials / Completed
CompletedNCT00239317
Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Tamusulosin is effective in the treatment of lower urinary tract syndrome with male patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tamusulosin |
Timeline
- First posted
- 2005-10-17
- Last updated
- 2007-10-22
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00239317. Inclusion in this directory is not an endorsement.